MedPath

To evaluate the effect of Ayurveda treatment Compared to allopath Treatment in the Management of Amavata (Rheumatoid Arthritis)

Phase 2/3
Not yet recruiting
Conditions
Rheumatoid arthritis with rheumatoid factor, unspecified. Ayurveda Condition: AMAVATAH,
Registration Number
CTRI/2023/05/053230
Lead Sponsor
All India institute of ayurveda
Brief Summary

Rheumatoid Arthritis (RA) is a common systemic autoimmune disease that 1% of the world’s population is suffering from it. Epidemiological surveys by WHO –COPCORD(WHO community oriented program for control of rheumatoid disease) shows a prevalence of 0.45% in urban India and 0.7%in rural population, The disease, in addition to reducing the average life expectancy of patients, is associated with significant morbidity. So that 50% of RA patients are not able to continue their jobs after ten years of illness .

In Ayurveda commonly used in all the diseases is Samshodhana and Shamana. Samshodhana indicates the Dosha eliminating process, Whereas Shaman brings into equilibrium the aggravated Doshas in the body. Each type of procedure is having its equal importance in their respective way.

In modern medical science with extreme advancement in diagnostic approach, It is a challenging disease for the physicians and medical field. Disease-modifying anti-rheumatic drugs (DMARDs) are standard medication for RA patients, methotrexate is one of the commonly used drug to suppress autoimmune response but its side effects is notorious

Amavata is one of the devastating diseases that cause permanent disability. The condition is named for its two main pathogenic components, Ama and Vata. these two factors simultaneously take part in theSamprapti making it difficult to treat. According to samprapti wherever this Ama gets localized in the body tissue or joints, it can lead to production of pain, stiffness, swelling, tenderness in related joints.[8] It is not just a problem of the locomotor system; it is also a systemic disease.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
78
Inclusion Criteria
  • 1.Chronicity: < 5 years.
  • 2.Presence of minimum 2 clinical features of Amavata (SandhiShoola,Sandhi Stabdhata) 3.RA (seropositive ) 4.The subjects who will fullfill the ACR-EULAR Criteria:2010 (presence of total score ≥ 6 from criteria) 5.Preferably freshly diagnosed cases of Rheumatoid arthritis / old cases after the washout period of one month.
Exclusion Criteria
  • Juvenile R.A. 2.Chronicity: > 5 years.
  • 3.Not willing to participate in the study.
  • 4.Patients with tuberculosis ,Hypertension ,pregnant women.
  • Patients unfit for Swedana & Basti.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reduction in disease activity DAS -28Reduction in disease activity DAS -28 | • Relief in Cardinal Symptoms such as Pain (Shoola), shotha (swelling), stabdhata (stiffness) ,Range of movements as compared to earlier life style in the patients of Amavata [Rheumatoid artheritis].
• Relief in Cardinal Symptoms such as Pain (Shoola), shotha (swelling), stabdhata (stiffness) ,Range of movements as compared to earlier life style in the patients of Amavata [Rheumatoid artheritis].Reduction in disease activity DAS -28 | • Relief in Cardinal Symptoms such as Pain (Shoola), shotha (swelling), stabdhata (stiffness) ,Range of movements as compared to earlier life style in the patients of Amavata [Rheumatoid artheritis].
Secondary Outcome Measures
NameTimeMethod
Development of a comprehensive Ayurveda score for Amavata (CASA).• Improvement in HAQ-DI the quality of life .

Trial Locations

Locations (1)

All India institute of ayurveda

🇮🇳

Delhi, DELHI, India

All India institute of ayurveda
🇮🇳Delhi, DELHI, India
Poonam verma
Principal investigator
8377885153
dr.poonamverma235@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.